相关实验视频

Updated: Jun 16, 2025

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Published on: May 5, 2023

人类干扰素调节因子3 (IRF-3) 在膜巨细胞中的表达与COPD的临床和功能特征有关

Simonetta Baraldo¹, Matteo Bonato^1,2, Sebastiano Cassia^3,4

¹Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy.

Respiratory research

|August 19, 2024

概括

在慢性阻塞性肺病 (COPD) 中,吸烟会增加先天免疫反应. 然而,在COPD患者中,较低的IRF-3表达与严重的气流阻塞和更多的恶化相关.

科学领域:

免疫学免疫学免疫学
肺部病理学肺部病理学
细胞生物学细胞生物学

背景情况:

慢性阻塞性肺病 (COPD) 是疾病和死亡的主要原因,通常与免疫调节失调有关.
虽然在COPD中发现了增强的免疫反应,但最近的发现表明患者的干扰素 (IFN) 信号通路受损.

研究的目的:

研究COPD患者外周肺部中关键的先天性免疫成分,包括IFN受体 (IFNAR1/IFNAR2),IRF-3和MDA-5的表达.
评估这些免疫标记物,临床特征和炎症细胞概况之间的相关性.

主要方法:

从58个人获得肺组织样本:22名COPD患者,21名肺功能正常的吸烟者 (SC) 和15名非吸烟者对照 (nSC).
免疫组织化学被用来量化IFNAR1,IFNAR2,IRF-3,MDA-5,埃索诺菲尔和肺组织中激活的NK细胞 (NKp46+) 的表达.

主要成果:

与nSC相比,COPD和SC组的IRF-3阳性膜巨细胞显著增加.
在COPD患者中,较低的IRF-3水平与FEV1降低和恶化率增加相关. 慢性支气管炎 (CB) 也与较低的IRF-3相关.
激活的NK细胞 (NKp46+) 在COPD患者中升高,而异于eosinophils.

结论:

吸烟会提高天生的免疫反应,由IRF-3阳性膜巨细胞和NKp46+细胞的增加表明.
在COPD中,降低IRF-3表达与更高的恶化率,严重的气流阻塞和慢性支气管炎有关.
这些发现表明,先天性免疫反应与COPD的特定临床特征有关.

关键词:

限制空气流的限制慢性支气管炎是一种慢性支气管炎.恶化的情况加剧.这是天生的免疫力.

更多相关视频

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

Published on: January 24, 2016

In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure

In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure

Published on: October 22, 2019

相关概念视频

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: